Breaking down walls in prostate cancer with the MURAL collection of patient-derived xenografts

A bank of 59 well-characterised prostate cancer patient-derived xenografts was established, including 17 classed as research-ready covering the disease-spectrum which, plus associated resources (organoids, serum, DNA/RNA profiles, tissue), are available for collaborative projects. This eagerly-antic...

Descripción completa

Detalles Bibliográficos
Autor principal: Bevan, Charlotte L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448875/
https://www.ncbi.nlm.nih.gov/pubmed/34535657
http://dx.doi.org/10.1038/s41467-021-25783-1
Descripción
Sumario:A bank of 59 well-characterised prostate cancer patient-derived xenografts was established, including 17 classed as research-ready covering the disease-spectrum which, plus associated resources (organoids, serum, DNA/RNA profiles, tissue), are available for collaborative projects. This eagerly-anticipated resource will facilitate pre-clinical prostate cancer therapy studies.

Ejemplares similares